New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S4770

Introduced
10/27/25  

Caption

Implements Blue Band Program to address preeclampsia in New Jersey.

Impact

By implementing the Blue Band Program, New Jersey seeks to significantly reduce the incidence of preventable pregnancy-related complications tied to preeclampsia, which has been identified as a leading cause of maternal mortality within the state. By ensuring that at-risk individuals are easily identifiable, healthcare providers can prioritize interventions that could prevent adverse outcomes. The bill highlights the financial implications of preeclampsia, which adds considerable costs to maternal care, and aims to offset these costs by enhancing early detection and management of the condition. Statistically, the implementation of this program could lower adverse maternal outcomes considerably, from 10.1% to 4.6%, thus improving maternal survival rates and overall newborn outcomes.

Summary

Bill S4770, known as the Blue Band Program, aims to establish a state-wide initiative in New Jersey to improve outcomes related to preeclampsia—a serious pregnancy complication that can have severe implications for both maternal and infant health. The bill mandates that the Office of Maternal and Child Health develop and implement a program that provides identifiable blue wristbands to pregnant and postpartum individuals who are at risk of preeclampsia. This initiative intends to clearly inform healthcare providers about a patient's risk factors, promoting better monitoring and follow-up care throughout the pregnancy and postpartum periods.

Contention

While the bill presents a proactive approach to managing maternal health, there may be varying perspectives on its implementation. Proponents argue that such programs are essential in reducing mortality and should be embraced for their potential to save lives and reduce healthcare costs. However, critics could point to issues of healthcare access, equity, and the adequacy of resources allocated for training and monitoring hospitals that participate in the program. The effective execution of this initiative will require careful consideration of the needs of diverse populations across New Jersey to ensure that all mothers receive appropriate and timely care.

Companion Bills

NJ A6056

Same As Implements Blue Band Program to address preeclampsia in New Jersey.

Previously Filed As

NJ S299

Implements Blue Band Program to address preeclampsia in New Jersey.

NJ A2188

Establishes requirements to evaluate certain people who are pregnant and who have given birth for preeclampsia.

NJ A2200

Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.

NJ S594

Requires school districts to provide instruction on risks of compulsive gambling as part of implementation of New Jersey Student Learning Standards in Comprehensive Health and Physical Education.

NJ S3821

Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.

NJ J01943

Memorializing Governor Kathy Hochul to proclaim May 2026, as Preeclampsia Awareness Month in the State of New York

NJ S1318

Creates New Jersey Innocence Study and Review Commission.

NJ SJR74

Designates first week of March as "Civic Learning Week" in New Jersey.

NJ S243

Increases benefit amount under New Jersey Earned Income Tax Credit program from 40 percent to 60 percent of federal benefit amount.

NJ S1265

Provides for Medicaid coverage of certain home blood pressure monitors and cuffs for pregnant persons at risk for preeclampsia.

Similar Bills

NJ S299

Implements Blue Band Program to address preeclampsia in New Jersey.

PA HR517

Recognizing the month of May 2026 as "Preeclampsia Awareness Month" in Pennsylvania.

NJ A2188

Establishes requirements to evaluate certain people who are pregnant and who have given birth for preeclampsia.

PA HR158

Designating the month of May 2025 as "Preeclampsia Awareness Month" in Pennsylvania.

NY J01943

Memorializing Governor Kathy Hochul to proclaim May 2026, as Preeclampsia Awareness Month in the State of New York

NJ S3821

Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.

NJ A2200

Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.

TN SB0205

AN ACT to amend Tennessee Code Annotated, Title 56; Title 63; Title 68 and Title 71, relative to coverage of biomarker testing for preeclampsia.